Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Carrieri, A; Centeno, NB; Rodrigo, J; Sanz, F; Carotti, A
   Theoretical evidence of a salt bridge disruption as the initiating processfor the alpha(1d)-adrenergic receptor activation: a molecular dynamics anddocking study
   PROTEINS-STRUCTURE FUNCTION AND GENETICS
   
   A. Carrieri et al., "Theoretical evidence of a salt bridge disruption as the initiating processfor the alpha(1d)-adrenergic receptor activation: a molecular dynamics anddocking study", PROTEINS, 43(4), 2001, pp. 382-394
2. Sautel, M; Milligan, G
   Molecular manipulation of G-protein-coupled receptors: A new avenue into drug discovery
   CURRENT MEDICINAL CHEMISTRY
   
   M. Sautel e G. Milligan, "Molecular manipulation of G-protein-coupled receptors: A new avenue into drug discovery", CURR MED CH, 7(9), 2000, pp. 889-896
3. Horn, F; van der Wenden, EM; Oliveira, L; IJzerman, AP; Vriend, G
   Receptors coupling to G proteins: Is there a signal behind the sequence?
   PROTEINS-STRUCTURE FUNCTION AND GENETICS
   
   F. Horn et al., "Receptors coupling to G proteins: Is there a signal behind the sequence?", PROTEINS, 41(4), 2000, pp. 448-459
4. Scheer, A; Costa, T; Fanelli, F; De Benedetti, PG; Mhaouty-Kodja, S; Abuin, L; Nenniger-Tosato, M; Cotecchia, S
   Mutational analysis of the highly conserved arginine within the Glu/Asp-Arg-Tyr motif of the alpha(1b)-adrenergic receptor: Effects on receptor isomerization and activation
   MOLECULAR PHARMACOLOGY
   
   A. Scheer et al., "Mutational analysis of the highly conserved arginine within the Glu/Asp-Arg-Tyr motif of the alpha(1b)-adrenergic receptor: Effects on receptor isomerization and activation", MOLEC PHARM, 57(2), 2000, pp. 219-231
5. Meyer, CK; Bohme, M; Ockenfels, A; Gartner, W; Hofmann, KP; Ernst, OP
   Signaling states of rhodopsin - Retinal provides a scaffold for activatingproton transfer switches
   JOURNAL OF BIOLOGICAL CHEMISTRY
   
   C.K. Meyer et al., "Signaling states of rhodopsin - Retinal provides a scaffold for activatingproton transfer switches", J BIOL CHEM, 275(26), 2000, pp. 19713-19718
6. Reggio, PH
   Ligand-ligand and ligand-receptor approaches to modeling the cannabinoid CB1 and CB2 receptors: Achievements and challenges
   CURRENT MEDICINAL CHEMISTRY
   
   P.H. Reggio, "Ligand-ligand and ligand-receptor approaches to modeling the cannabinoid CB1 and CB2 receptors: Achievements and challenges", CURR MED CH, 6(8), 1999, pp. 665-683
7. Schulz, A; Schoneberg, T; Paschke, R; Schultz, G; Gudermann, T
   Role of the third intracellular loop for the activation of gonadotropin receptors
   MOLECULAR ENDOCRINOLOGY
   
   A. Schulz et al., "Role of the third intracellular loop for the activation of gonadotropin receptors", MOL ENDOCR, 13(2), 1999, pp. 181-190
8. Schoneberg, T; Schultz, G; Gudermann, T
   Structural basis of G protein-coupled receptor function
   MOLECULAR AND CELLULAR ENDOCRINOLOGY
   
   T. Schoneberg et al., "Structural basis of G protein-coupled receptor function", MOL C ENDOC, 151(1-2), 1999, pp. 181-193
9. Iwasiow, RM; Nantel, MF; Tiberi, M
   Delineation of the structural basis for the activation properties of the dopamine D1 receptor subtypes
   JOURNAL OF BIOLOGICAL CHEMISTRY
   
   R.M. Iwasiow et al., "Delineation of the structural basis for the activation properties of the dopamine D1 receptor subtypes", J BIOL CHEM, 274(45), 1999, pp. 31882-31890
10. Lu, ZL; Hulme, EC
    The functional topography of transmembrane domain 3 of the M-1 muscarinic acetylcholine receptor, revealed by scanning mutagenesis
    JOURNAL OF BIOLOGICAL CHEMISTRY
    
    Z.L. Lu e E.C. Hulme, "The functional topography of transmembrane domain 3 of the M-1 muscarinic acetylcholine receptor, revealed by scanning mutagenesis", J BIOL CHEM, 274(11), 1999, pp. 7309-7315
11. STEFAN CJ; OVERTON MC; BLUMER KJ
    MECHANISMS GOVERNING THE ACTIVATION AND TRAFFICKING OF YEAST G-PROTEIN-COUPLED RECEPTORS
    Molecular biology of the cell
    
    C.J. Stefan et al., "MECHANISMS GOVERNING THE ACTIVATION AND TRAFFICKING OF YEAST G-PROTEIN-COUPLED RECEPTORS", Molecular biology of the cell, 9(4), 1998, pp. 885-899
12. FANELLI F; MENZIANI C; SCHEER A; COTECCHIA S; DEBENEDETTI PG
    AB-INITIO MODELING AND MOLECULAR-DYNAMICS SIMULATION OF THE ALPHA(1B)-ADRENERGIC RECEPTOR ACTIVATION
    Methods
    
    F. Fanelli et al., "AB-INITIO MODELING AND MOLECULAR-DYNAMICS SIMULATION OF THE ALPHA(1B)-ADRENERGIC RECEPTOR ACTIVATION", Methods, 14(3), 1998, pp. 302-317
13. CHAHDI A; DAEFFLER L; GIES JP; LANDRY Y
    DRUGS INTERACTING WITH G-PROTEIN ALPHA-SUBUNITS - SELECTIVITY AND PERSPECTIVES
    Fundamental and clinical pharmacology
    
    A. Chahdi et al., "DRUGS INTERACTING WITH G-PROTEIN ALPHA-SUBUNITS - SELECTIVITY AND PERSPECTIVES", Fundamental and clinical pharmacology, 12(2), 1998, pp. 121-132
14. DUBE P; KONOPKA JB
    IDENTIFICATION OF A POLAR-REGION IN TRANSMEMBRANE DOMAIN-6 THAT REGULATES THE FUNCTION OF THE G-PROTEIN-COUPLED ALPHA-FACTOR RECEPTOR
    Molecular and cellular biology (Print)
    
    P. Dube e J.B. Konopka, "IDENTIFICATION OF A POLAR-REGION IN TRANSMEMBRANE DOMAIN-6 THAT REGULATES THE FUNCTION OF THE G-PROTEIN-COUPLED ALPHA-FACTOR RECEPTOR", Molecular and cellular biology (Print), 18(12), 1998, pp. 7205-7215
15. Colson, AO; Perlman, JH; Jinsi-Parimoo, A; Nussenzveig, DR; Osman, R; Gershengorn, MC
    A hydrophobic cluster between transmembrane helices 5 and 6 constrains thethyrotropin-releasing hormone receptor in an inactive conformation
    MOLECULAR PHARMACOLOGY
    
    A.O. Colson et al., "A hydrophobic cluster between transmembrane helices 5 and 6 constrains thethyrotropin-releasing hormone receptor in an inactive conformation", MOLEC PHARM, 54(6), 1998, pp. 968-978
16. GANGULI SC; PARK CG; HOLTMANN MH; HADAC EM; KENAKIN TP; MILLER LJ
    PROTEAN EFFECTS OF A NATURAL PEPTIDE AGONIST OF THE G-PROTEIN-COUPLEDSECRETIN RECEPTOR DEMONSTRATED BY RECEPTOR MUTAGENESIS
    The Journal of pharmacology and experimental therapeutics
    
    S.C. Ganguli et al., "PROTEAN EFFECTS OF A NATURAL PEPTIDE AGONIST OF THE G-PROTEIN-COUPLEDSECRETIN RECEPTOR DEMONSTRATED BY RECEPTOR MUTAGENESIS", The Journal of pharmacology and experimental therapeutics, 286(2), 1998, pp. 593-598
17. GETHER U; KOBILKA BK
    G-PROTEIN-COUPLED RECEPTORS - II - MECHANISM OF AGONIST ACTIVATION
    The Journal of biological chemistry
    
    U. Gether e B.K. Kobilka, "G-PROTEIN-COUPLED RECEPTORS - II - MECHANISM OF AGONIST ACTIVATION", The Journal of biological chemistry, 273(29), 1998, pp. 17979-17982
18. SHI W; SPORTS CD; RAMAN D; SHIRAKAWA S; OSAWA S; WEISS ER
    RHODOPSIN ARGININE-135 MUTANTS ARE PHOSPHORYLATED BY RHODOPSIN KINASEAND BIND ARRESTIN IN THE ABSENCE OF 11-CIS-RETINAL
    Biochemistry
    
    W. Shi et al., "RHODOPSIN ARGININE-135 MUTANTS ARE PHOSPHORYLATED BY RHODOPSIN KINASEAND BIND ARRESTIN IN THE ABSENCE OF 11-CIS-RETINAL", Biochemistry, 37(14), 1998, pp. 4869-4874
19. BOURNE HR
    HOW RECEPTORS TALK TO TRIMERIC G-PROTEINS
    Current opinion in cell biology
    
    H.R. Bourne, "HOW RECEPTORS TALK TO TRIMERIC G-PROTEINS", Current opinion in cell biology, 9(2), 1997, pp. 134-142
20. KAYE PV; HAPGOOD J; MILLAR RP
    ABSENCE OF MUTATIONS IN EXON-3 OF THE GNRH RECEPTOR IN HUMAN GONADOTROPH ADENOMAS
    Clinical endocrinology
    
    P.V. Kaye et al., "ABSENCE OF MUTATIONS IN EXON-3 OF THE GNRH RECEPTOR IN HUMAN GONADOTROPH ADENOMAS", Clinical endocrinology, 47(5), 1997, pp. 549-554
21. HERRICKDAVIS K; EGAN C; TEITLER M
    ACTIVATING MUTATIONS OF THE SEROTONIN 5-HT2C RECEPTOR
    Journal of neurochemistry
    
    K. Herrickdavis et al., "ACTIVATING MUTATIONS OF THE SEROTONIN 5-HT2C RECEPTOR", Journal of neurochemistry, 69(3), 1997, pp. 1138-1144
22. PARDO L; CAMPILLO M; GIRALDO J
    THE EFFECT OF THE MOLECULAR MECHANISM OF G-PROTEIN-COUPLED RECEPTOR ACTIVATION ON THE PROCESS OF SIGNAL-TRANSDUCTION
    European journal of pharmacology
    
    L. Pardo et al., "THE EFFECT OF THE MOLECULAR MECHANISM OF G-PROTEIN-COUPLED RECEPTOR ACTIVATION ON THE PROCESS OF SIGNAL-TRANSDUCTION", European journal of pharmacology, 335(1), 1997, pp. 73-87
23. RAO VR; OPRIAN DD
    ACTIVATING MUTATIONS OF RHODOPSIN AND OTHER G-PROTEIN-COUPLED RECEPTORS
    Annual review of biophysics and biomolecular structure
    
    V.R. Rao e D.D. Oprian, "ACTIVATING MUTATIONS OF RHODOPSIN AND OTHER G-PROTEIN-COUPLED RECEPTORS", Annual review of biophysics and biomolecular structure, 25, 1996, pp. 287-314
24. BARON J; WINER KK; YANOVSKI JA; CUNNINGHAM AW; LAUE L; ZIMMERMAN D; CUTLER GB
    MUTATIONS IN THE CA2-SENSING RECEPTOR GENE CAUSE AUTOSOMAL-DOMINANT AND SPORADIC HYPOPARATHYROIDISM()
    Human molecular genetics
    
    J. Baron et al., "MUTATIONS IN THE CA2-SENSING RECEPTOR GENE CAUSE AUTOSOMAL-DOMINANT AND SPORADIC HYPOPARATHYROIDISM()", Human molecular genetics, 5(5), 1996, pp. 601-606
25. VANRHEE AM; JACOBSON KA
    MOLECULAR ARCHITECTURE OF G-PROTEIN-COUPLED RECEPTORS
    Drug development research
    
    A.M. Vanrhee e K.A. Jacobson, "MOLECULAR ARCHITECTURE OF G-PROTEIN-COUPLED RECEPTORS", Drug development research, 37(1), 1996, pp. 1-38
26. BUCZYLKO J; SAARI JC; CROUCH RK; PALCZEWSKI K
    MECHANISMS OF OPSIN ACTIVATION
    The Journal of biological chemistry
    
    J. Buczylko et al., "MECHANISMS OF OPSIN ACTIVATION", The Journal of biological chemistry, 271(34), 1996, pp. 20621-20630
27. QUITTERER U; ABDALLA S; JARNAGIN K; MULLERESTERL W
    NA-2 RECEPTOR SUPPRESS AGONIST-INDEPENDENT RECEPTOR ACTIVATION( IONS BINDING TO THE BRADYKININ B)
    Biochemistry
    
    U. Quitterer et al., "NA-2 RECEPTOR SUPPRESS AGONIST-INDEPENDENT RECEPTOR ACTIVATION( IONS BINDING TO THE BRADYKININ B)", Biochemistry, 35(41), 1996, pp. 13368-13377
28. BIRNBAUMER M
    MUTATIONS AND DISEASES OF G-PROTEIN COUPLED RECEPTORS
    Journal of receptor and signal transduction research
    
    M. Birnbaumer, "MUTATIONS AND DISEASES OF G-PROTEIN COUPLED RECEPTORS", Journal of receptor and signal transduction research, 15(1-4), 1995, pp. 131-160
29. LUDGATE ME; VASSART G
    THE THYROTROPIN RECEPTOR AS A MODEL TO ILLUSTRATE RECEPTOR AND RECEPTOR ANTIBODY DISEASES
    Bailliere's clinical endocrinology and metabolism
    
    M.E. Ludgate e G. Vassart, "THE THYROTROPIN RECEPTOR AS A MODEL TO ILLUSTRATE RECEPTOR AND RECEPTOR ANTIBODY DISEASES", Bailliere's clinical endocrinology and metabolism, 9(1), 1995, pp. 95-113
30. FANELLI F; MENZIANI MC; DEBENEDETTI PG
    COMPUTER-SIMULATIONS OF SIGNAL-TRANSDUCTION MECHANISM IN ALPHA(1B)-ADRENERGIC AND M3-MUSCARINIC-RECEPTORS
    Protein engineering
    
    F. Fanelli et al., "COMPUTER-SIMULATIONS OF SIGNAL-TRANSDUCTION MECHANISM IN ALPHA(1B)-ADRENERGIC AND M3-MUSCARINIC-RECEPTORS", Protein engineering, 8(6), 1995, pp. 557-564
31. HEIN L; KOBILKA BK
    NEUROTRANSMITTER RECEPTORS .4. ADRENERGIC-RECEPTOR SIGNAL-TRANSDUCTION AND REGULATION
    Neuropharmacology
    
    L. Hein e B.K. Kobilka, "NEUROTRANSMITTER RECEPTORS .4. ADRENERGIC-RECEPTOR SIGNAL-TRANSDUCTION AND REGULATION", Neuropharmacology, 34(4), 1995, pp. 357-366
32. DUPREZ L; PARMA J; VANSANDE J; ALLGEIER A; LECLERE J; SCHVARTZ C; DELISLE MJ; DECOULX M; ORGIAZZI J; DUMONT J; VASSART G
    GERMLINE MUTATIONS IN THE THYROTROPIN RECEPTOR GENE CAUSE NON-AUTOIMMUNE AUTOSOMAL-DOMINANT HYPERTHYROIDISM
    Nature genetics
    
    L. Duprez et al., "GERMLINE MUTATIONS IN THE THYROTROPIN RECEPTOR GENE CAUSE NON-AUTOIMMUNE AUTOSOMAL-DOMINANT HYPERTHYROIDISM", Nature genetics, 7(3), 1994, pp. 396-401